Latest Iris Biotechnologies (IRSB) Headlines
Post# of 4
Iris BioTechnologies Appoints Paul Yaswen, Ph.D. as Chief Scientific Officer
Business Wire - Tue Oct 29, 2:44PM CDT
Iris BioTechnologies Inc. (OTCBB:IRSB), a life sciences company poised to set new standards of precision in diagnosis and therapeutics, is pleased to announce that Paul Yaswen, Ph.D., has been appointed to the newly created position of Chief Scientific Officer. In this role, he will have broad responsibilities in scientific research and launching new products. Iris welcomes Dr. Yaswen to our team.